We are live on ! Find out more
SIC

Salem Investment Counselors Portfolio holdings

AUM $4.03B
1-Year Est. Return 61.49%
This Fund
S&P 500
This Quarter Est. Return
+3.9%
1 Year Est. Return
+61.49%
3 Year Est. Return
+158.64%
5 Year Est. Return
+203.54%
10 Year Est. Return
+1,118.52%
AUM
$3.1B
AUM Growth
+$54.5M
Cap. Flow
-$1.67M
Cap. Flow %
-0.05%
Top 10 Hldgs %
49.33%
Holding
1,221
New
52
Increased
175
Reduced
264
Closed
55

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$3.97M
2
EVH icon
Evolent Health
EVH
+$2.7M
3
NOW icon
ServiceNow
NOW
+$2.45M
4
XOM icon
ExxonMobil
XOM
+$2.28M
5
TERN
Terns Pharmaceuticals
TERN
+$2.25M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$9.58M
2
HUN icon
Huntsman Corp
HUN
+$3.66M
3
PXD
Pioneer Natural Resource Co.
PXD
+$2.29M
4
AAPL icon
Apple
AAPL
+$2.05M
5
BMY icon
Bristol-Myers Squibb
BMY
+$1.83M

Sector Composition

Rank Sector Weight
1 Technology 27.45%
2 Consumer Discretionary 24.54%
3 Healthcare 9.58%
4 Financials 9.34%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNST icon
576
Renasant Corp
RNST
$4B
$45.6K ﹤0.01%
1,493
SPEM icon
577
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
$45.2K ﹤0.01%
1,200
CASY icon
578
Casey's General Stores
CASY
$31.5B
$45K ﹤0.01%
118
LYB icon
579
LyondellBasell Industries
LYB
$20.2B
$45K ﹤0.01%
470
CMS icon
580
CMS Energy
CMS
$22.1B
$44.9K ﹤0.01%
755
GDV icon
581
Gabelli Dividend & Income Trust
GDV
$2.69B
$44.9K ﹤0.01%
1,979
NLY icon
582
Annaly Capital Management
NLY
$17.6B
$44.6K ﹤0.01%
2,263
VRSK icon
583
Verisk Analytics
VRSK
$23.4B
$44.5K ﹤0.01%
165
VCIT icon
584
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.9B
$44.4K ﹤0.01%
555
-237
-30% -$18.8K
FBNC icon
585
First Bancorp
FBNC
$2.73B
$44.4K ﹤0.01%
1,380
KALU icon
586
Kaiser Aluminum
KALU
$3.06B
$44K ﹤0.01%
500
SCHZ icon
587
Schwab US Aggregate Bond ETF
SCHZ
$10.6B
$43.7K ﹤0.01%
1,918
-2
-0.1% -$45
UTG icon
588
Reaves Utility Income Fund
UTG
$3.68B
$43.6K ﹤0.01%
+1,596
New +$43.5K
DAIO icon
589
Data I/O
DAIO
$31.4M
$43.6K ﹤0.01%
15,796
CR icon
590
Crane Co
CR
$12.7B
$43.5K ﹤0.01%
300
DSL
591
DoubleLine Income Solutions Fund
DSL
$1.24B
$43.4K ﹤0.01%
3,463
+30
+0.9% +$373
RPM icon
592
RPM International
RPM
$14.4B
$43.1K ﹤0.01%
400
IIIV icon
593
i3 Verticals
IIIV
$316M
$43.1K ﹤0.01%
1,950
O icon
594
Realty Income
O
$59.8B
$42.8K ﹤0.01%
810
-200
-20% -$10.7K
IYC icon
595
iShares US Consumer Discretionary ETF
IYC
$1.22B
$42.6K ﹤0.01%
+524
New +$41.7K
EXAS
596
DELISTED
Exact Sciences
EXAS
$42.3K ﹤0.01%
1,002
PBPB
597
DELISTED
Potbelly
PBPB
$42.1K ﹤0.01%
5,239
GILD icon
598
Gilead Sciences
GILD
$170B
$41.6K ﹤0.01%
607
SNX icon
599
TD Synnex
SNX
$20.6B
$41.2K ﹤0.01%
357
FHLC icon
600
Fidelity MSCI Health Care Index ETF
FHLC
$3.42B
$41.2K ﹤0.01%
600

Similar funds

Salem Investment Counselors's Q2 2024 Portfolio in Review

As of Q2 2024, Salem Investment Counselors held 1,221 positions worth $3.1B, up 1.8% from $3.05B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Salem Investment Counselors's Q2 2024 filing shows 52 new, 175 increased, 264 reduced and 55 closed positions. Its largest new stake was Terns Pharmaceuticals: 371,600 shares worth $2.53M. The largest sale was NVIDIA, an estimated $9.58M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Salem Investment Counselors's largest Q2 2024 buy was Terns Pharmaceuticals: 371,600 shares worth $2.53M.
  • Salem Investment Counselors added most to Visa in Q2 2024, an estimated $3.97M increase.
  • Salem Investment Counselors's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $9.58M.
  • Salem Investment Counselors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $2.29M.
  • Salem Investment Counselors's ten largest holdings make up 49% of its $3.1B portfolio in Q2 2024.
  • Salem Investment Counselors opened 52 new positions and closed 55 in Q2 2024.
  • Salem Investment Counselors's portfolio value rose 1.8% quarter-over-quarter to $3.1B.

Based on Salem Investment Counselors's 13F filing for Q2 2024, filed 11 Jul 2024.